Journal article
M. Lledós, V. Mirabello, S. Sarpaki, H. Ge, H. J. Smugowski, L. Carroll, E. Aboagye, F. Aigbirhio, S. Botchway, J. Dilworth, D. G. Calatayud, P. Plucinski, G. Price, S. Pascu
ChemNanoMat, 2018
ChemNanoMat, 2018
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Lledós, M., Mirabello, V., Sarpaki, S., Ge, H., Smugowski, H. J., Carroll, L., … Pascu, S. (2018). Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics. ChemNanoMat.
Chicago/Turabian
Click to copy
Lledós, M., V. Mirabello, S. Sarpaki, H. Ge, H. J. Smugowski, L. Carroll, E. Aboagye, et al. “Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics.” ChemNanoMat (2018).
MLA
Click to copy
Lledós, M., et al. “Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics.” ChemNanoMat, 2018.
BibTeX Click to copy
@article{m2018a,
title = {Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics},
year = {2018},
journal = {ChemNanoMat},
author = {Lledós, M. and Mirabello, V. and Sarpaki, S. and Ge, H. and Smugowski, H. J. and Carroll, L. and Aboagye, E. and Aigbirhio, F. and Botchway, S. and Dilworth, J. and Calatayud, D. G. and Plucinski, P. and Price, G. and Pascu, S.}
}
Abstract
Abstract Molecular imaging has become a powerful technique in preclinical and clinical research aiming towards the diagnosis of many diseases. In this work, we address the synthetic challenges in achieving lab‐scale, batch‐to‐batch reproducible copper‐64‐ and gallium‐68‐radiolabelled metal nanoparticles (MNPs) for cellular imaging purposes. Composite NPs incorporating magnetic iron oxide cores with luminescent quantum dots were simultaneously encapsulated within a thin silica shell, yielding water‐dispersible, biocompatible and luminescent NPs. Scalable surface modification protocols to attach the radioisotopes 64Cu (t1/2=12.7 h) and 68Ga (t1/2=68 min) in high yields are reported, and are compatible with the time frame of radiolabelling. Confocal and fluorescence lifetime imaging studies confirm the uptake of the encapsulated imaging agents and their cytoplasmic localisation in prostate cancer (PC‐3) cells. Cellular viability assays show that the biocompatibility of the system is improved when the fluorophores are encapsulated within a silica shell. The functional and biocompatible SiO2 matrix represents an ideal platform for the incorporation of 64Cu and 68Ga radioisotopes with high radiolabelling incorporation.
